HLA association and occurrence of autoantibodies in Asian-Indian patients with ulcerative colitis

American Journal of Gastroenterology

Volumn 92, Issue 5, 1997, Pages 772-776

  Habeeb, M A ^a   Rajalingam, R ^a   Dhar, A ^a   Kumar, A ^a   Sharma, M P ^a   Mehra, N K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; HLA ANTIGEN CLASS 1; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; ASIAN; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENE LOCUS; HLA SYSTEM; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; COLITIS, ULCERATIVE; FEMALE; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; INDIA; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 0031008210     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993;342:407-11.
2. Lewkonia RM, McConnel RB. Familial inflammatory bowel disease. Heredity or environment? Gut 1976;17:235-9.
3. Satsangi J, Rosenberg WMC, Jewell DP. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Eur J Gastroenterol Hepatol 1994;6:413-6.
4. Asakura H, Tsuchiya M, Aiso S, et al. Association of the human lymphocyte DR2 antigen with Japanese ulcerative colitis. Gastroenterology 1982;82:413-8.
5. Kobayashi K, Atoh M, Konoeda Y, et al. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis. Clin Exp Immunol 1990;80:400-3.
6. Nahir M, Gideoni O, Eidelman S, et al. HLA antigens in ulcerative colitis. Lancet 1976;2:573.
7. Delpre G, Kadish U, Gazit E, et al. HLA antigens in ulcerative colitis and Crohn's disease in Israel. Gastroenterology 1980;78:1452-7.
8. Biemond I, Burnham WR, D'Amaro J, et al. HLA-A and -B antigens in inflammatory bowel disease. Gut 1986;27:934-41.
9. Saxon A, Shanahan F, Landers G, et al. A subset of antineutrophil anticytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
10. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J 1955;2:1041.
11. Calin A. Ankylosing spondylitis. In: Kelley WN, Harris ED, Ruddy S, et al., eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1989:1021-37.
12. Terasaki PI, McCelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998-1000.
13. Friou GJ. Clinical application of lupus serum nucleoprotein reaction using fluorescent antibody technique. J Clin Invest 1957;36:890.
14. Vander Woude FJ, Rasmussen N, Lombatto S, et al. Autoantibodies against neutrophils and monocytes: A new tool for diagnosis and a marker of disease activity in Wegener's granulomatosos. Lancet 1985; 2:425-9.
15. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-11.
16. Tandon BN, Mathur AK, Mohapatra LN, et al. A study of the prevalence and clinical pattern of non-specific ulcerative colitis in Northern India. Gut 1965;6:448-53.
17. Chuttani HK, Nigam S, Sama SK, et al. Ulcerative colitis in the tropics. Br Med J 1967;4:204-7.
18. Antia FP, Kairo RH, Gandhi MK, et al. Ulcerative colitis: Its prevalence in socioeconomic groups. Indian J Gastroenterol 1985;4:19-20.
19. Kapur P, Aggarwal SK, Prakash P, et al. Idiopathic ulcerative colitis in Northern India. Indian J Gastroenterol 1986;5:247-8.
20. Sharma MP, Sarin SK. Ulcerative colitis in a North Indian hospital: Current trends. J R Coll Physicians Lond1985;19:99-102.
21. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis. Medicine 1976;55: 401-12.
22. Danzi JT. Extra intestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297-302.
23. Kochhar R, Mehta SK, Nagi B, et al. Extraintestinal manifestations of Idiopathic ulcerative colitis. Indian J Gastroenterol 1991;10:88-9.
24. Farmer RG, Easley LA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis: A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46.
25. Malaviya AN, Mehra NK, Adhar GC, et al. HLA-B27 in patients with seronegative spondyloarthropathies. J Rheumatol 1979;6:413-6.
26. Khan MA. HLA-B27 subtypes in world populations. Curr Opinions Rheumatol 1995;7:263-9.
27. Mayer L, Janowitz HD. Extraintestinal manifestations. In: Allan RN, Keighley MRB, Alexander-Williams J, et al., eds. Inflammatory bowel diseases. London: Churchill-Livingstone; 1990:501-11.
28. Sharma MP, Kar P, Malaviya AN. Autoantibodies in ulcerative colitis. J Assoc Physicians India 1982;30:29-30.
29. Snook JA, Chapman RW, Fleming K, et al. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30-3.
30. Oudkerpool M, Ellerbroek PM, Ridwan BV, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis: A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical and surgical treatment. Gut 1993;34:46-50.
31. Kanga U, Mehra NK, Larrea CL, et al. Seronegative spondyloarthropathies and HLA-B27 subtypes: A study in Asian Indians. Clin Rheumatol 1996;15(suppl 1):13-8.
32. Mehra NK, Rajalingam R, Sagar S, et al. Direct role of HLA-B5 in influencing susceptibility to Takayasu aortoarteritis. Int J Cardiol 1996;54:555-63.
33. Mehra NK, Rajalingam R, Giphart MJ. Generation of DR51-associated DQA1, DQB1 haplotypes in Asian Indians. Tissue Antigens 1995;47: 85-9.
34. Taneja V, Giphart MJ, Verduijn W, et al. Polymorphism of DRB, DQA1 and DQB1 in rheumatoid arthritis in Asian Indians: Association with DRB1*0405 and DRB1*1001. Hum Immunol 1996;46:35-41.